Home › Funds › Brandes U.S. Value ETF
Fund family: 2023 ETF Series Trust · Filed by 2023 ETF Series Trust (CIK 1969674) · SEC series S000081644
Ticker: BUSA (C000244571)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 833 with, 42 against, 0 abstentions (not counted as with management). Shareholder proposals: 19 FOR, 23 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other 2023 ETF Series Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 90.9% of this fund’s 875 such votes could be given a sector; the other 80 (9.1%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 197 | 15 | 7.6% |
| Health Care | 146 | 9 | 6.2% |
| Consumer Discretionary | 139 | 7 | 5.0% |
| Technology | 110 | 5 | 4.5% |
| Industrials | 71 | 1 | 1.4% |
| Energy | 60 | 3 | 5.0% |
| Consumer Staples | 44 | 1 | 2.3% |
| Telecommunications | 14 | 1 | 7.1% |
| Utilities | 14 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 643 | 0 |
| Say-on-Pay | 62 | 0 |
| Audit-related | 61 | 0 |
| Compensation | 33 | 0 |
| Corporate Governance | 27 | 14 |
| Shareholder Rights and Defenses | 19 | 11 |
| Capital Structure | 12 | 0 |
| Environment or Climate | 6 | 6 |
| Other Social Issues | 6 | 6 |
| Human Rights or Human Capital/workforce | 3 | 3 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Micron Technology, Inc. | January 15, 2026 | $12M | 12 | 1 |
| Merck & Co., Inc. | May 26, 2026 | $9M | 18 | 3 |
| Cardinal Health, Inc. | November 5, 2025 | $9M | 14 | 0 |
| Citigroup Inc. | May 20, 2026 | $8M | 16 | 0 |
| The Cigna Group | April 22, 2026 | $7M | 15 | 1 |
| Pfizer Inc. | April 23, 2026 | $7M | 16 | 1 |
| Johnson & Johnson | April 23, 2026 | $7M | 15 | 1 |
| Textron Inc. | April 29, 2026 | $7M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| January 15, 2026 | Micron Technology, Inc. | Shareholder Proposal Requesting Amendment To Shareholder Special Meeting Right. Shareholder proposal | For | Against |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 22, 2026 | The Cigna Group | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposal | For | Against |
| April 23, 2026 | Pfizer Inc. | Adopt an Independent Chair Policy Shareholder proposal | For | Against |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | For | Against |
| May 27, 2026 | Chevron Corporation | Adopt an Independent Chair Shareholder proposal | For | Against |
| May 27, 2026 | Chevron Corporation | Report on Indigenous Peoples Rights Shareholder proposal | Against | For |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting independent board chair Shareholder proposal | Against | For |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposal | Against | For |
| April 28, 2026 | Wells Fargo & Company | Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposal | Against | For |
| April 28, 2026 | Wells Fargo & Company | Shareholder Proposal - Govern by Majority Vote. Shareholder proposal | Against | For |
876 ballot items at 66 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Brandes U.S. Value ETF (BUSA) voted at 66 shareholder meetings of 62 companies, on 876 ballot items in all. Where management made a recommendation, the fund followed it on 95.2% of the items and voted against it 42 times. Its most frequent area of disagreement was corporate governance (14 of its votes against management). It voted on 42 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.